一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Palbociclib Impurity 105
Palbociclib Impurity 105
  • Palbociclib Impurity 105
  • Palbociclib Impurity 105
  • Palbociclib Impurity 105
  • Palbociclib Impurity 105
  • Palbociclib Impurity 105

Palbociclib Impurity 105 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-12-16

Product Details

Product Name: Palbociclib Impurity 105 CAS No.: 1779124-68-3
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/12/16
Molecular Formula: C14H20N4O4

Palbociclib Impurity;1779124-68-3

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Code:P005105

  • English Name:Palbociclib Impurity 105

  • English Alias:tert-butyl 4-(2-nitropyridin-3-yl)piperazine-1-carboxylate

  • CAS No.:1779124-68-3

  • Molecular Formula:C??H??N?O?

  • Molecular Weight:308.33

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Palbociclib impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol-acetonitrile mixture within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 105 in Palbociclib API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors impurity formation during Palbociclib synthesis, reducing generation by >30% by adjusting nitration temperature (e.g., 0-5℃) and reaction time.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Palbociclib, a CDK4/6 inhibitor, regulates the cell cycle to inhibit tumor growth and is clinically used for combined therapy of HR+/HER2- advanced breast cancer. Impurity 105, a nitro-containing impurity in its synthesis, may originate from pyridine ring nitration by-products or incomplete piperazine group protection. Its nitro, tert-butoxycarbonyl, and piperazine ring may affect drug synthesis efficiency, in vivo metabolism, and safety. Strict impurity control for anticancer drugs is critical to treatment efficacy and patient safety, making research on this impurity essential for drug quality control.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 7 minutes, with LOD of 0.005 ng/mL for high-precision trace impurity analysis.

  • Formation Mechanism:Formed by nitration of tert-butyl 4-(3-pyridyl)piperazine-1-carboxylate in nitric acid-sulfuric acid systems; optimizing nitrating agent ratio and reaction pH inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC?? of 198.4 μM against MCF-7 cells (Palbociclib IC??=7.6 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor nitro reduction degradation under high temperature and humidity conditions


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 


Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2026-07-27
VIP3Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2026-03-12
$83.00
VIP4Y
TargetMol Chemicals Inc.
2026-07-15
INQUIRY
龙岩市| 紫云| 南阳市| 昭平县| 察哈| 确山县| 武山县| 宿松县| 保康县| 昭苏县| 浑源县| 大庆市| 卫辉市| 东兴市| 八宿县| 红河县| 梁河县| 林口县| 凤庆县| 盐津县| 华蓥市| 简阳市| 长顺县| 南澳县| 株洲县| 禄劝| 邯郸市| 无锡市| 广平县| 大厂| 铜鼓县| 绥芬河市| 乐陵市| 洮南市| 卢龙县| 静宁县| 彭山县| 沽源县| 思南县| 章丘市| 基隆市|